Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam.

NCT03644784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 354

Last updated 2019-08-07

No results posted yet for this study

Summary

The ASSESS-REGURGE is a multicenter, multicontinental registry on protocoled aortographic image acquisition after implantation of a transcatheter aortic valve. After the implementation of the acquisition protocol, each participating site will use the standardized approach for their center in order to identify if the images are considered analyzable via videodensitometry quantitative assessment of aortic regurgitation.

Conditions

  • Aortic Valve Insufficiency
  • Aortic Valve Regurgitation

Interventions

DIAGNOSTIC_TEST

Standardized protocol for assessing aortic regurgitation using videodensitometry

Standardized protocol for assessing aortic regurgitation using videodensitometry

Sponsors & Collaborators

  • Yamaguchi University Hospital

    collaborator OTHER
  • Segeberger Kliniken GmbH

    collaborator OTHER
  • McGill University

    collaborator OTHER
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • Imperial College London

    lead OTHER

Principal Investigators

  • Patrick W Serruys, MD, PhD · Imperial College London

  • Rodrigo Modolo, MD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  • Yoshinobu Onuma, MD, PhD · Erasmus Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2019-03-01
Completion
2019-03-31

Countries

  • Canada
  • Germany
  • Japan
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03644784 on ClinicalTrials.gov